Brief: Gabather Study Shows GT-002 To Be Safe And Well-Tolerated

Gabather AB

19/06/2019 12:53

June 19 (Reuters) - Gabather AB  GABAT.ST :
    * STUDY SHOWS THAT  GT-002 IS SAFE AND WELL-TOLERATED WITH
ORAL
ADMINISTRATION
    * NOTED NO NEGATIVE IMPACT ON BLOOD IMAGE, BLOOD CHEMISTRY
OR
ORGAN SYSTEMS
    * RESULTS ALSO SHOW THAT GT-002 DOES NOT HAVE ANY SEDATIVE
EFFECT
AT THE DOSES TESTED

Source text for Eikon:  ID:nWkrc6zB96 
Further company coverage:  GABAT.ST 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))